Network bioinformatics analysis provides insight into drug repurposing for COVID-19

The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xu, Yu, Jinchao, Zhang, Zhiming, Ren, Jing, Peluffo, Alex E., Zhang, Wen, Zhao, Yujie, Wu, Jiawei, Yan, Kaijing, Cohen, Daniel, Wang, Wenjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008783/
https://www.ncbi.nlm.nih.gov/pubmed/33817623
http://dx.doi.org/10.1016/j.medidd.2021.100090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008783/
https://www.ncbi.nlm.nih.gov/pubmed/33817623
http://dx.doi.org/10.1016/j.medidd.2021.100090

Ejemplares similares